ArticleResearch and practice in thrombosis and haemostasis2022

Recombinant single-chain factor VIII in severe hemophilia: Long-term safety and efficacy in previously treated patients in the AFFINITY extension study.

Johnny Mahlangu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.